Amanta Healthcare Ltd IPO will open for investors from 1st September 2025 to 3rd September 2025. The company is planning to raise ₹126 crore through this IPO. The price band is fixed at ₹120 to ₹126 per share, and the lot size is 119 shares, so the minimum money needed for retail investors is about ₹14,994. This issue is a fresh issue of 1 crore shares and will be listed on both BSE and NSE around 8th–9th September 2025. The raised money will be used for new manufacturing projects (SteriPort and SVP lines) and general company work.
We provide daily IPO updates, stock market insights, GMP prices, company financials, and allotment news in simple language. Our aim is to help investors understand IPOs easily so they can make informed decisions.
About Amanta Healthcare Ltd.
Amanta Healthcare Ltd. is a Gujarat-based pharmaceutical company engaged in manufacturing sterile liquid products and medical devices. The company has more than two decades of experience in healthcare manufacturing and is recognized for high-quality production standards.
Its product portfolio includes:
- IV fluids
- Ophthalmic solutions
- Irrigation solutions
- Medical devices using ABFS and ISBM technology
Amanta Healthcare also exports its products to international markets. With strong research and development, modern manufacturing facilities, and a skilled team, the company has created a niche in the Indian healthcare sector.
Amanta Healthcare Ltd IPO Details
| Particulars | Details |
|---|---|
| IPO Type | Book Built Issue |
| IPO Opening Date | 1 September 2025 |
| IPO Closing Date | 3 September 2025 |
| Price Band | ₹120 – ₹126 per share |
| Issue Size | ₹126 Crore (Fresh Issue of 1 Crore Shares) |
| Face Value | ₹10 per share |
| Exchange Listing | NSE, BSE |
| Listing Date | 8 September 2025 (expected) |
| Registrar | MUFG Intime India Pvt. Ltd. |
| Lead Manager | Beeline Capital Advisors Pvt. Ltd. |
This IPO is a 100% fresh issue. No Offer for Sale (OFS) is included, which means the entire proceeds will be used for company growth.
Objectives of the IPO
Amanta Healthcare plans to use the funds raised from this IPO for the following purposes:
- ₹70 crore for expansion of SteriPort manufacturing facility
- ₹30.13 crore for establishing a new SVP production line
- ₹25.9 crore for general corporate purposes
The objective is to expand production capacity, meet increasing market demand, and strengthen the company’s financial stability.
Amanta Healthcare Ltd IPO Dates
- IPO Open Date: 1 September 2025
- IPO Close Date: 3 September 2025
- Allotment Finalization: 4 September 2025
- Refunds Initiation: 5 September 2025
- Shares Credit to Demat: 8 September 2025
- Listing Date: 8 September 2025 (some reports suggest 9 September)
Lot Size and Investment
Lot Size
- Lot Size: 119 Shares
- Minimum Investment: ₹14,994 (119 × ₹126)
- Maximum Retail Investment: Around ₹1.94 lakh (1,547 shares)
Investors Allocation
| Category | Allocation % | Shares Offered |
|---|---|---|
| QIB (Institutions) | 20% | 20,00,000 |
| NII (HNI) | 15% | 15,00,000 |
| Retail Investors | 35% | 35,00,000 |
| Anchor Investors | 30% | 30,00,000 |
This balanced allocation ensures participation from retail investors as well as institutions.
Amanta Healthcare Financial Statements
The company’s financial performance shows a positive trend in recent years:
| Financial Year | Revenue (₹ Crore) | Profit After Tax (₹ Crore) |
|---|---|---|
| FY23 | 225.6 | 3.2 |
| FY24 | 248.3 | 3.6 |
| FY25 | 274.7 | 10.5 |
Key highlights:
- Revenue increased steadily year after year.
- Profit after tax grew nearly three times in FY25 compared to FY24.
- Rising profitability indicates stronger operations and efficient cost management.
Amanta Healthcare IPO GMP Price
The Grey Market Premium (GMP) is reflecting strong investor sentiment.
- Current GMP: ₹22–₹26 above the issue price
- Expected Listing Gain: Around 20% premium over the upper band
This indicates that the IPO is likely to list at a higher price, giving early investors good chances of short-term profit.
Conclusion
The Amanta Healthcare IPO looks promising for investors who want to participate in India’s growing healthcare and pharmaceutical sector. The company has a strong product portfolio, rising revenues, and significantly improved profits. Its focus on expanding manufacturing capacity shows long-term vision.
The positive GMP trend suggests good listing gains, but investors should also consider risks such as market competition and valuation. For long-term investors, the expansion and financial growth may provide sustainable returns.
Disclaimer
This article is only for informational and educational purposes. It is not investment advice. Investors should consult their financial advisor before making any investment decisions in the Amanta Healthcare IPO or the stock market.
SBI Raise 25000 Crore QIP: India’s Biggest Share Sale Explained
